Belkin UltraGlass screen protectors for the iPhone 14 lineup now available
Belkin, a global consumer electronics leader, today introduces the Belkin UltraGlass Screen Protector engineered and designed for iPhone 14, iPhone 14 Plus, iPhone 14 Pro and iPhone 14 Pro Max. Featuring ultra-impact protection that’s up to 2X stronger than tempered glass protectors, the UltraGlass delivers even more screen protection for iPhone. It is available to order now on apple.com.
iPhone 14 and iPhone 14 Pro include industry-leading durability features like the Ceramic Shield front cover, exclusive to iPhone and tougher than any smartphone glass. Providing even more protection, the Belkin UltraGlass Screen Protector joins the company’s vast portfolio of award-winning screen protection offerings for iPhone and is the best glass to date. It delivers first-of-its-kind German-engineered lithium aluminosilicate (LAS) glass for added strength, flexibility and scratch resistance to protect iPhone 14 models. Chemically strengthened through a double-ion exchange process, UltraGlass is two times stronger than tempered glass, proven to have 2 times better drop protection and provides best-in-class performance for added impact and scratch protection while maintaining a flawless touchscreen experience.
Package includes Belkin UltraGlass Screen Protector, cleaning cloth and dust removal sticker to prevent air bubbles, and patented Easy Align tray for flawless alignment and fool-proof application.
Pricing and Availability
The Belkin UltraGlass Screen Protector collection for the iPhone 14, iPhone 14 Plus, iPhone 14 Pro, and iPhone 14 Pro Max is available on apple.com today for $39.95 USD and coming later this month to Apple Store locations worldwide.
Professional screen protection application via Screen Protection Application System available at Apple Store locations worldwide; customers must purchase screen protector in-store.
For more Belkin screen protection offerings, see the SCREENFORCE™ collection for iPhone here: https://www.belkin.com/us/screen-protectors/c/iphone-protect/
Imagery available for download here.
Belkin is an accessories market leader delivering power, protection, productivity, connectivity, audio and smart home solutions for a broad range of consumer electronics and enterprise environments. Designed in Southern California and sold in more than 50 countries around the world, Belkin creates products that empower people through technology whether at home, at work or on a new adventure. In 2018, Belkin International merged with Foxconn Interconnect Technology to bolster its global influence and remains forever inspired by people and the planet we live on.
© 2022 Belkin International, Inc. and/or its affiliates. All rights reserved.
All product names, logos, and brands are property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Vice President of Global Communications and Corporate Development
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SoftServe Named as a Challenger in 2023 Gartner Magic Quadrant for Custom Software Development Services, Worldwide4.12.2023 18:31:00 CET | Press release
SoftServe, a premier IT consulting and digital services provider, today announced it has been named by Gartner® as a Challenger in the 2023 Magic Quadrant™ for Custom Software Development Services, Worldwide. SoftServe was recognized for its ability to execute and completeness of vision. “SoftServe is recognized throughout the market as a preferred partner for some of the world’s leading technology providers and enterprises,” said Alex Chubay, SoftServe’s CTO. “Our approach involves a holistic perspective encompassing business acumen, user experience, cloud and data engineering, along with cutting-edge technologies – such as Generative AI – that enable our clients to build award-winning digital products and transform their businesses.” Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. For more than
Limited Libations, Innovative Blending, Escapism Elixirs and More are Shaping the Way That Consumers Drink in 2024, Based on the Bacardi Cocktail Trends Report4.12.2023 16:40:00 CET | Press release
Bacardi Limited, the world’s largest privately held international spirits company, releases its fifth annual Bacardi Cocktail Trends Report, anticipating the key trends that will redefine cocktail culture and the spirits business in 2024. The report, created in collaboration with strategic foresight consultancy, The Future Laboratory (TFL), draws on insights from Bacardi-led and external research, interviews with bartenders and insights from The Future Laboratory to share the themes that are transforming flavor preferences, drink formats, and cocktail experiences in the coming year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231202332985/en/ Find out what's in store for 2024 with the Bacardi Cocktail Trends Report. (Graphic: Business Wire) “As 2024 arrives, people are looking to settle into the unsettled – welcoming tastes of optimism into our reality. In this landscape, people are reshaping cocktail culture, infusing it
Visa and Oxfam America to Explore Expanding Anticipatory Action Program to Bring Pre-Disaster Financial Support to the Philippines, Kenya, Colombia, and Puerto Rico4.12.2023 15:00:00 CET | Press release
During the 28th United Nations Climate Change Conference (COP28), Visa (NYSE: V), a global leader in digital payments, and Oxfam America, a part of the global Oxfam organization fighting inequality to end poverty and injustice, announced intent to collaborate to scale Oxfam’s Building Resilient, Adaptive and Disaster-Ready Communities (B-READY) project to deliver real-time streamlined money movement and relief payments to individuals and businesses in the Philippines, Kenya, Colombia, and Puerto Rico. B-READY unites parametric forecasting with community inputs to provide humanitarian assistance to individuals, communities, and businesses before a disaster strikes. Visa and Oxfam America intend to scale B-READY to create a mobile-based payment solution infrastructure to digitize humanitarian payments to help families, individuals, and small businesses protect themselves and their assets before a disaster. Combining data-driven insights from Visa with Oxfam’s record of disaster relief an
QPS Holdings, LLC Expands Operations in Springfield, Missouri4.12.2023 14:30:00 CET | Press release
QPS Holdings, LLC, a global contract research organization has expanded operations in Springfield, Missouri. The new facilities include a clinical (safety) laboratory, an updated self-contained pharmacy, and a new dedicated space to build and ship clinical trial kits. The 2,750-square-foot facility is fully operational as of the fall of 2023 and will give QPS significant flexibility in clinical research study operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231204471818/en/ QPS Missouri is a division of QPS Holdings, LLC, a global Contract Research Organization. QPS Missouri conducts Phase I-IV clinical trials in Springfield, Missouri, and has recently added a new safety laboratory, updated pharmacy, and clinical trial kit production facility. (Photo: Business Wire) The state-of-the art laboratory is equipped with the most up-to-date technologies for Chemistry, Urinalysis, Serology, Coagulation, and Hematology test
Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib4.12.2023 14:00:00 CET | Press release
Merck, a leading science and technology company, today announced a license agreement with Abbisko Therapeutics Co. Ltd., Shanghai, China, for pimicotinib (ABSK021), which is currently being evaluated in a Phase III study for the treatment of tenosynovial giant cell tumor (TGCT). TGCT is a benign tumor of the joints that can cause swelling, pain, stiffness, and limited mobility of the affected joints. Treatment options for this disease, which can seriously affect patients’ quality of life, are very limited. The agreement grants Merck a license to commercialize pimicotinib in mainland China, Hong Kong, Macau and Taiwan, with an option for rest of world. “We have the opportunity through our partnership with Abbisko to deliver a first-in-class treatment for a critically underserved patient population in China and potentially beyond,” said Andrew Paterson, Chief Marketing Officer for the Healthcare business sector of Merck. “Pimicotinib provides an opportunity to address a significant unmet